These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
2851 |
|
||||||||||||
(State or other jurisdiction of
incorporation or organization) |
(Primary Standard Industrial
Classification Code Number) |
(I.R.S. Employer
Identification No.) |
|
|
|
||||||||||||
(Title of class) | (Trading symbol) | (Exchange on which registered) |
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Net sales | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Cost of goods sold |
|
|
|
|
||||||||||||||||||||||
Selling, general and administrative expenses |
|
|
|
|
||||||||||||||||||||||
Other operating charges |
|
|
|
|
||||||||||||||||||||||
Research and development expenses |
|
|
|
|
||||||||||||||||||||||
Amortization of acquired intangibles |
|
|
|
|
||||||||||||||||||||||
Income from operations |
|
|
|
|
||||||||||||||||||||||
Interest expense, net |
|
|
|
|
||||||||||||||||||||||
Other expense, net |
|
|
|
|
||||||||||||||||||||||
Income before income taxes |
|
|
|
|
||||||||||||||||||||||
Provision for income taxes |
|
|
|
|
||||||||||||||||||||||
Net income |
|
|
|
|
||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests |
|
|
|
(
|
||||||||||||||||||||||
Net income attributable to controlling interests | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Basic net income per share | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Diluted net income per share | $ |
|
$ |
|
$ |
|
$ |
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Net income | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Other comprehensive income (loss), before tax: | ||||||||||||||||||||||||||
Foreign currency translation adjustments |
|
(
|
|
(
|
||||||||||||||||||||||
Unrealized gain (loss) on derivatives |
|
|
(
|
|
||||||||||||||||||||||
Unrealized gain on pension and other benefit plan obligations |
|
|
|
|
||||||||||||||||||||||
Other comprehensive income (loss), before tax |
|
(
|
|
(
|
||||||||||||||||||||||
Income tax provision (benefit) related to items of other comprehensive income (loss) |
|
|
(
|
|
||||||||||||||||||||||
Other comprehensive income (loss), net of tax |
|
(
|
|
(
|
||||||||||||||||||||||
Comprehensive income (loss) |
|
(
|
|
|
||||||||||||||||||||||
Less: Comprehensive (loss) income attributable to noncontrolling interests |
(
|
|
(
|
|
||||||||||||||||||||||
Comprehensive income (loss) attributable to controlling interests | $ |
|
$ |
(
|
$ |
|
$ |
|
June 30, 2023 | December 31, 2022 | |||||||||||||
Assets | ||||||||||||||
Current assets: | ||||||||||||||
Cash and cash equivalents | $ |
|
$ |
|
||||||||||
Restricted cash |
|
|
||||||||||||
Accounts and notes receivable, net |
|
|
||||||||||||
Inventories |
|
|
||||||||||||
Prepaid expenses and other current assets |
|
|
||||||||||||
Total current assets |
|
|
||||||||||||
Property, plant and equipment, net |
|
|
||||||||||||
Goodwill |
|
|
||||||||||||
Identifiable intangibles, net |
|
|
||||||||||||
Other assets |
|
|
||||||||||||
Total assets | $ |
|
$ |
|
||||||||||
Liabilities, Shareholders’ Equity | ||||||||||||||
Current liabilities: | ||||||||||||||
Accounts payable | $ |
|
$ |
|
||||||||||
Current portion of borrowings |
|
|
||||||||||||
Other accrued liabilities |
|
|
||||||||||||
Total current liabilities |
|
|
||||||||||||
Long-term borrowings |
|
|
||||||||||||
Accrued pensions |
|
|
||||||||||||
Deferred income taxes |
|
|
||||||||||||
Other liabilities |
|
|
||||||||||||
Total liabilities |
|
|
||||||||||||
Commitments and contingent liabilities (Note 5) |
|
|
||||||||||||
Shareholders’ equity: | ||||||||||||||
Common shares, $
|
|
|
||||||||||||
Capital in excess of par |
|
|
||||||||||||
Retained earnings |
|
|
||||||||||||
Treasury shares, at cost,
|
(
|
(
|
||||||||||||
Accumulated other comprehensive loss |
(
|
(
|
||||||||||||
Total Axalta shareholders’ equity |
|
|
||||||||||||
Noncontrolling interests |
|
|
||||||||||||
Total shareholders’ equity |
|
|
||||||||||||
Total liabilities and shareholders’ equity | $ |
|
$ |
|
Common Stock | |||||||||||||||||||||||||||||||||||||||||||||||
Number of Shares | Par/Stated Value | Capital In Excess Of Par | Retained Earnings | Treasury Shares, at cost | Accumulated Other Comprehensive Loss | Non controlling Interests | Total | ||||||||||||||||||||||||||||||||||||||||
Balance at December 31, 2022 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
Comprehensive income: | |||||||||||||||||||||||||||||||||||||||||||||||
Net income | — | — | — |
|
— | — | — |
|
|||||||||||||||||||||||||||||||||||||||
Net realized and unrealized loss on derivatives, net of tax of $
|
— | — | — | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||
Long-term employee benefit plans, net of tax of $
|
— | — | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||
Foreign currency translation, net of tax benefit of $
|
— | — | — | — | — |
|
(
|
|
|||||||||||||||||||||||||||||||||||||||
Total comprehensive income | — | — | — |
|
— |
|
(
|
|
|||||||||||||||||||||||||||||||||||||||
Recognition of stock-based compensation | — | — |
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||
Shares issued under compensation plans |
|
|
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||
Balance at March 31, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
Comprehensive income: | |||||||||||||||||||||||||||||||||||||||||||||||
Net income | — | — | — |
|
— | — |
|
|
|||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain on derivatives, net of tax of $
|
— | — | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||
Long-term employee benefit plans, net of tax benefit of $
|
— | — | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||
Foreign currency translation, net of tax benefit of $
|
— | — | — | — | — |
|
(
|
|
|||||||||||||||||||||||||||||||||||||||
Total comprehensive income | — | — | — |
|
— |
|
(
|
|
|||||||||||||||||||||||||||||||||||||||
Recognition of stock-based compensation | — | — |
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||
Shares issued under compensation plans |
|
|
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||
Balance at June 30, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
Common Stock | |||||||||||||||||||||||||||||||||||||||||||||||
Number of Shares | Par/Stated Value | Capital In Excess Of Par | Retained Earnings | Treasury Shares, at cost | Accumulated Other Comprehensive Loss | Non controlling Interests | Total | ||||||||||||||||||||||||||||||||||||||||
Balance at December 31, 2021 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
Comprehensive income: | |||||||||||||||||||||||||||||||||||||||||||||||
Net income | — | — | — |
|
— | — |
(
|
|
|||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain on derivatives, net of tax of $
|
— | — | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||
Long-term employee benefit plans, net of tax of $
|
— | — | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||
Foreign currency translation, net of tax of $
|
— | — | — | — | — |
(
|
|
(
|
|||||||||||||||||||||||||||||||||||||||
Total comprehensive income | — | — | — |
|
— |
|
(
|
|
|||||||||||||||||||||||||||||||||||||||
Recognition of stock-based compensation | — | — |
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||
Shares issued under compensation plans |
|
|
(
|
— | — | — | — |
(
|
|||||||||||||||||||||||||||||||||||||||
Changes in ownership of noncontrolling interests | — | — |
(
|
— | — | — |
|
(
|
|||||||||||||||||||||||||||||||||||||||
Common stock purchases |
(
|
— | — | — |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||||||||||||
Dividends declared to noncontrolling interests | — | — | — | — | — | — |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||
Balance at March 31, 2022 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
Comprehensive income: | |||||||||||||||||||||||||||||||||||||||||||||||
Net income | — | — | — |
|
— | — | — |
|
|||||||||||||||||||||||||||||||||||||||
Net realized and unrealized gain on derivatives, net of tax benefit of $
|
— | — | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||
Long-term employee benefit plans, net of tax of $
|
— | — | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||
Foreign currency translation, net of tax of $
|
— | — | — | — | — |
(
|
|
(
|
|||||||||||||||||||||||||||||||||||||||
Total comprehensive income | — | — | — |
|
— |
(
|
|
(
|
|||||||||||||||||||||||||||||||||||||||
Recognition of stock-based compensation | — | — |
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||
Shares issued under compensation plans |
|
|
(
|
— | — | — | — |
(
|
|||||||||||||||||||||||||||||||||||||||
Common stock purchases |
(
|
— | — | — |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||||||||||||
Balance at June 30, 2022 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
Six Months Ended
June 30, |
||||||||||||||
2023 | 2022 | |||||||||||||
Operating activities: | ||||||||||||||
Net income | $ |
|
$ |
|
||||||||||
Adjustment to reconcile net income to cash provided by (used for) operating activities: | ||||||||||||||
Depreciation and amortization |
|
|
||||||||||||
Amortization of deferred financing costs and original issue discount |
|
|
||||||||||||
Debt extinguishment and refinancing related costs |
|
(
|
||||||||||||
Deferred income taxes |
|
|
||||||||||||
Realized and unrealized foreign exchange losses, net |
|
|
||||||||||||
Stock-based compensation |
|
|
||||||||||||
Divestiture and impairment charges |
|
|
||||||||||||
Interest income on swaps designated as net investment hedges |
(
|
(
|
||||||||||||
Commercial agreement restructuring charge |
|
|
||||||||||||
Other non-cash, net |
|
(
|
||||||||||||
Changes in operating assets and liabilities: | ||||||||||||||
Trade accounts and notes receivable |
(
|
(
|
||||||||||||
Inventories |
|
(
|
||||||||||||
Prepaid expenses and other assets |
(
|
(
|
||||||||||||
Accounts payable |
(
|
|
||||||||||||
Other accrued liabilities |
(
|
(
|
||||||||||||
Other liabilities |
(
|
(
|
||||||||||||
Cash provided by (used for) operating activities |
|
(
|
||||||||||||
Investing activities: | ||||||||||||||
Purchase of property, plant and equipment |
(
|
(
|
||||||||||||
Interest proceeds on swaps designated as net investment hedges |
|
|
||||||||||||
Settlement proceeds on swaps designated as net investment hedges |
|
|
||||||||||||
Other investing activities, net |
|
(
|
||||||||||||
Cash used for investing activities |
(
|
(
|
||||||||||||
Financing activities: | ||||||||||||||
Proceeds from short-term borrowings |
|
|
||||||||||||
Payments on short-term borrowings |
(
|
(
|
||||||||||||
Payments on long-term borrowings |
(
|
(
|
||||||||||||
Financing-related costs |
(
|
(
|
||||||||||||
Purchases of common stock |
|
(
|
||||||||||||
Net cash flows associated with stock-based awards |
|
(
|
||||||||||||
Deferred acquisition-related consideration |
(
|
|
||||||||||||
Other financing activities, net |
|
(
|
||||||||||||
Cash used for financing activities |
(
|
(
|
||||||||||||
Decrease in cash |
(
|
(
|
||||||||||||
Effect of exchange rate changes on cash |
|
(
|
||||||||||||
Cash at beginning of period |
|
|
||||||||||||
Cash at end of period | $ |
|
$ |
|
||||||||||
Cash at end of period reconciliation: | ||||||||||||||
Cash and cash equivalents | $ |
|
$ |
|
||||||||||
Restricted cash |
|
|
||||||||||||
Cash at end of period | $ |
|
$ |
|
Note | Page | |||||||
Performance
Coatings |
Mobility
Coatings |
Total | ||||||||||||||||||
Balance at December 31, 2022 | $ |
|
$ |
|
$ |
|
||||||||||||||
Purchase accounting adjustments and divestitures |
(
|
(
|
(
|
|||||||||||||||||
Foreign currency translation |
|
|
|
|||||||||||||||||
Balance at June 30, 2023 | $ |
|
$ |
|
$ |
|
June 30, 2023 |
Gross Carrying
Amount |
Accumulated
Amortization |
Net Book
Value |
Weighted average
amortization periods (years) |
||||||||||||||||||||||
Technology | $ |
|
$ |
(
|
$ |
|
|
|||||||||||||||||||
Trademarks—indefinite-lived |
|
— |
|
Indefinite | ||||||||||||||||||||||
Trademarks—definite-lived |
|
(
|
|
|
||||||||||||||||||||||
Customer relationships |
|
(
|
|
|
||||||||||||||||||||||
Total | $ |
|
$ |
(
|
$ |
|
December 31, 2022 |
Gross Carrying
Amount |
Accumulated
Amortization |
Net Book
Value |
Weighted average
amortization periods (years) |
||||||||||||||||||||||
Technology | $ |
|
$ |
(
|
$ |
|
|
|||||||||||||||||||
Trademarks—indefinite-lived |
|
— |
|
Indefinite | ||||||||||||||||||||||
Trademarks—definite-lived |
|
(
|
|
|
||||||||||||||||||||||
Customer relationships |
|
(
|
|
|
||||||||||||||||||||||
Other |
|
(
|
|
|
||||||||||||||||||||||
Total | $ |
|
$ |
(
|
$ |
|
Remainder of 2023 | $ |
|
||||||
2024 |
|
|||||||
2025 |
|
|||||||
2026 |
|
|||||||
2027 |
|
|||||||
2028 |
|
2023 Activity | ||||||||
Balance at December 31, 2022 | $ |
|
||||||
Expenses, net of changes to estimates |
|
|||||||
Payments made |
(
|
|||||||
Foreign currency translation |
|
|||||||
Balance at June 30, 2023 | $ |
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Components of net periodic benefit cost:
|
||||||||||||||||||||||||||
Net periodic benefit cost: | ||||||||||||||||||||||||||
Service cost | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Interest cost |
|
|
|
|
||||||||||||||||||||||
Expected return on plan assets |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Amortization of actuarial losses, net |
|
|
|
|
||||||||||||||||||||||
Amortization of prior service cost, net |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Net periodic benefit cost | $ |
|
$ |
|
$ |
|
$ |
|
Stock Options |
Awards
(in millions) |
Weighted
Average Exercise Price |
Aggregate
Intrinsic Value (in millions) |
Weighted
Average Remaining Contractual Life (years) |
||||||||||||||||||||||
Outstanding at January 1, 2023 |
|
$ |
|
|||||||||||||||||||||||
Granted |
|
$ |
|
|||||||||||||||||||||||
Exercised |
(
|
$ |
|
|||||||||||||||||||||||
Forfeited / Expired |
(
|
$ |
|
|||||||||||||||||||||||
Outstanding at June 30, 2023 |
|
$ |
|
|||||||||||||||||||||||
Vested and expected to vest at June 30, 2023 |
|
$ |
|
$ |
|
|
||||||||||||||||||||
Exercisable at June 30, 2023 |
|
$ |
|
$ |
|
|
Restricted Stock Units |
Units
(in millions) |
Weighted Average
Fair Value |
||||||||||||
Outstanding at January 1, 2023 |
|
$ |
|
|||||||||||
Granted |
|
$ |
|
|||||||||||
Vested |
(
|
$ |
|
|||||||||||
Forfeited |
(
|
$ |
|
|||||||||||
Outstanding at June 30, 2023 |
|
$ |
|
Performance Share Units |
Units
(in millions) |
Weighted Average
Fair Value |
||||||||||||
Outstanding at January 1, 2023 |
|
$ |
|
|||||||||||
Granted |
|
$ |
|
|||||||||||
Vested |
|
$ |
|
|||||||||||
Forfeited |
(
|
$ |
|
|||||||||||
Outstanding at June 30, 2023 |
|
$ |
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Foreign exchange losses, net | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Debt extinguishment and refinancing related costs |
|
(
|
|
(
|
||||||||||||||||||||||
Other miscellaneous (income) expense, net
(1)
|
(
|
|
(
|
|
||||||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
Six Months Ended
June 30, |
||||||||||||||
2023 | 2022 | |||||||||||||
Effective Tax Rate |
|
% |
|
% |
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||||||
(In millions, except per share data) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Net income to common shareholders | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Basic weighted average shares outstanding |
|
|
|
|
||||||||||||||||||||||
Diluted weighted average shares outstanding |
|
|
|
|
||||||||||||||||||||||
Net income per common share: | ||||||||||||||||||||||||||
Basic net income per share | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Diluted net income per share | $ |
|
$ |
|
$ |
|
$ |
|
June 30, 2023 | December 31, 2022 | |||||||||||||
Accounts receivable - trade, net
(1)
|
$ |
|
$ |
|
||||||||||
Notes receivable |
|
|
||||||||||||
Other
(2)
|
|
|
||||||||||||
Total | $ |
|
$ |
|
June 30, 2023 | December 31, 2022 | |||||||||||||
Finished products | $ |
|
$ |
|
||||||||||
Semi-finished products |
|
|
||||||||||||
Raw materials |
|
|
||||||||||||
Stores and supplies |
|
|
||||||||||||
Total | $ |
|
$ |
|
June 30, 2023 | December 31, 2022 | |||||||||||||
Property, plant and equipment | $ |
|
$ |
|
||||||||||
Accumulated depreciation |
(
|
(
|
||||||||||||
Property, plant, and equipment, net | $ |
|
$ |
|
June 30, 2023 | December 31, 2022 | |||||||||||||
2029 Dollar Term Loans | $ |
|
$ |
|
||||||||||
2025 Euro Senior Notes |
|
|
||||||||||||
2027 Dollar Senior Notes |
|
|
||||||||||||
2029 Dollar Senior Notes |
|
|
||||||||||||
Short-term and other borrowings |
|
|
||||||||||||
Unamortized original issue discount |
(
|
(
|
||||||||||||
Unamortized deferred financing costs |
(
|
(
|
||||||||||||
Total borrowings, net |
|
|
||||||||||||
Less: | ||||||||||||||
Short-term borrowings |
|
|
||||||||||||
Current portion of long-term borrowings |
|
|
||||||||||||
Long-term debt | $ |
|
$ |
|
Remainder of 2023 | $ |
|
||||||
2024 |
|
|||||||
2025 |
|
|||||||
2026 |
|
|||||||
2027 |
|
|||||||
Thereafter |
|
|||||||
Total borrowings |
|
|||||||
Unamortized original issue discount |
(
|
|||||||
Unamortized deferred financing costs |
(
|
|||||||
Total borrowings, net | $ |
|
June 30, 2023 | December 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||||||||||||||||||||
Assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Prepaid expenses and other current assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Interest rate swaps
(1)
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||
Cross-currency swaps
(2)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Other assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Cross-currency swaps
(2)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Investments in equity securities
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Other accrued liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Cross-currency swaps
(2)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Contingent consideration |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Long-term borrowings: | ||||||||||||||||||||||||||||||||||||||||||||||||||
2029 Dollar Term Loans |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
2025 Euro Senior Notes |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
2027 Dollar Senior Notes |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
2029 Dollar Senior Notes |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Fair Value Using Significant Unobservable Inputs
(Level 3) |
||||||||
Beginning balance December 31, 2022
|
$ |
|
||||||
Payments |
(
|
|||||||
Change in fair value |
(
|
|||||||
Ending balance at June 30, 2023
|
$ |
|
||||||
Three Months Ended
June 30, |
||||||||||||||||||||||||||||||||
2023 | 2022 | |||||||||||||||||||||||||||||||
Derivatives in Cash Flow and Net Investment Hedges | Location of (Gain) Loss Recognized in Income on Derivatives | Net Amount of (Gain) Loss Recognized in OCI on Derivatives | Amount of Gain Recognized in Income | Net Amount of Gain Recognized in OCI on Derivatives | Amount of Loss (Gain) Recognized in Income | |||||||||||||||||||||||||||
Interest rate swaps | Interest expense, net | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||
Foreign currency forward contracts | Cost of goods sold |
|
(
|
(
|
|
|||||||||||||||||||||||||||
Cross-currency swaps
|
Interest expense, net |
|
(
|
(
|
(
|
Six Months Ended
June 30, |
||||||||||||||||||||||||||||||||
2023 | 2022 | |||||||||||||||||||||||||||||||
Derivatives in Cash Flow and Net Investment Hedges | Location of (Gain) Loss Recognized in Income on Derivatives | Net Amount of (Gain) Loss Recognized in OCI on Derivatives | Amount of Gain Recognized in Income | Net Amount of Gain Recognized in OCI on Derivatives | Amount of Loss (Gain) Recognized in Income | |||||||||||||||||||||||||||
Interest rate swaps | Interest expense, net | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||
Foreign currency forward contracts | Cost of goods sold |
|
(
|
(
|
|
|||||||||||||||||||||||||||
Cross-currency swaps
|
Interest expense, net |
|
(
|
(
|
(
|
Derivatives Not Designated as Hedging
Instruments under ASC 815 |
Location of (Gain) Loss Recognized in Income on Derivatives |
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||||||||
Foreign currency forward contracts | Other expense, net | $ |
(
|
$ |
|
$ |
(
|
$ |
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Net sales
(1)
:
|
||||||||||||||||||||||||||
Refinish | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Industrial |
|
|
|
|
||||||||||||||||||||||
Total Net sales Performance Coatings |
|
|
|
|
||||||||||||||||||||||
Light Vehicle |
|
|
|
|
||||||||||||||||||||||
Commercial Vehicle |
|
|
|
|
||||||||||||||||||||||
Total Net sales Mobility Coatings |
|
|
|
|
||||||||||||||||||||||
Total Net sales | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Depreciation and amortization expense
(2)
:
|
||||||||||||||||||||||||||
Performance Coatings | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Mobility Coatings |
|
|
|
|
||||||||||||||||||||||
Total Depreciation and amortization expense | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Segment Adjusted EBIT
(1)
:
|
||||||||||||||||||||||||||
Performance Coatings | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Mobility Coatings |
|
|
|
|
||||||||||||||||||||||
Total
(2)
|
|
|
|
|
||||||||||||||||||||||
Interest expense, net |
|
|
|
|
||||||||||||||||||||||
Debt extinguishment and refinancing-related costs (benefits)
(a)
|
|
(
|
|
(
|
||||||||||||||||||||||
Termination benefits and other employee-related costs
(b)
|
|
|
|
|
||||||||||||||||||||||
Acquisition and divestiture-related (benefits) costs
(c)
|
(
|
|
|
|
||||||||||||||||||||||
Impairment charges (benefits)
(d)
|
|
(
|
|
(
|
||||||||||||||||||||||
Accelerated depreciation and site closure costs
(e)
|
|
|
|
|
||||||||||||||||||||||
Russia sanction-related impacts
(f)
|
|
|
(
|
|
||||||||||||||||||||||
Commercial agreement restructuring impacts
(g)
|
|
|
|
|
||||||||||||||||||||||
Other adjustments
(h)
|
(
|
(
|
(
|
|
||||||||||||||||||||||
Income before income taxes | $ |
|
$ |
|
$ |
|
$ |
|
(1) | The primary measure of segment operating performance is Adjusted EBIT, which is defined as net income before interest, taxes and select other items impacting operating results. These other items impacting operating results are items that management has concluded are (1) certain non-cash items included within net income, (2) certain items the Company does not believe are indicative of ongoing operating performance or (3) certain non-recurring, unusual or infrequent items that have not occurred within the last two years or we believe are not reasonably likely to recur within the next two years. Adjusted EBIT is a key metric that is used by management to evaluate business performance in comparison to budgets, forecasts and prior year financial results, providing a measure that management believes reflects the Company's core operating performance, which represents Adjusted EBIT adjusted for the select items referred to above. | ||||
(2) |
Does not represent Adjusted EBIT referenced elsewhere by the Company as there are additional adjustments that are not allocated to the segments.
|
||||
(a) | Represents expenses and associated changes to estimates related to the prepayment, restructuring, and refinancing of our indebtedness, which are not considered indicative of our ongoing operating performance. | ||||
(b) | Represents expenses and associated changes to estimates related to employee termination benefits associated with restructuring programs and other employee-related costs. These amounts are not considered indicative of our ongoing operating performance. | ||||
(c) |
Represents acquisition and divestiture-related benefits, expenses and integration activities associated with our business combinations, all of which are not considered indicative of our ongoing operating performance. The amounts for the six months ended June 30, 2023 include $
|
||||
(d) |
Represents impairment charges and benefits, which are not considered indicative of our ongoing operating performance. The losses recorded during the three and six months ended June 30, 2023 were $
|
||||
(e) | Represents incremental depreciation expense resulting from truncated useful lives of the assets impacted by our manufacturing footprint assessments and costs related to the closure of certain manufacturing sites, which we do not consider indicative of our ongoing operating performance. | ||||
(f) |
Represents expenses and associated changes to estimates related to sanctions imposed on Russia in response to the conflict with Ukraine for incremental reserves on accounts receivable and inventory, which we do not consider indicative of our ongoing operating performance.
|
||||
(g) |
Represents a charge related to a customer concession discussed further in Note 2. This amount is not considered to be indicative of our ongoing operating performance.
|
||||
(h) | Represents costs for certain non-operational or non-cash (gains) losses, unrelated to our core business and which we do not consider indicative of our ongoing operating performance. |
Unrealized
Currency Translation Adjustments |
Pension
Adjustments |
Unrealized
Gain (Loss) on Derivatives |
Accumulated
Other Comprehensive (Loss) Income |
|||||||||||||||||||||||
Balance, December 31, 2022
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
Current year deferrals to AOCI |
|
|
|
|
||||||||||||||||||||||
Reclassifications from AOCI to Net income |
(
|
|
(
|
(
|
||||||||||||||||||||||
Net Change |
|
|
(
|
|
||||||||||||||||||||||
Balance, March 31, 2023
|
(
|
(
|
|
(
|
||||||||||||||||||||||
Current year deferrals to AOCI |
|
|
|
|
||||||||||||||||||||||
Reclassifications from AOCI to Net income |
(
|
|
(
|
(
|
||||||||||||||||||||||
Net Change |
|
|
|
|
||||||||||||||||||||||
Balance, June 30, 2023
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
Unrealized
Currency Translation Adjustments |
Pension
Adjustments |
Unrealized
(Loss) Gain on Derivatives |
Accumulated
Other Comprehensive (Loss) Income |
|||||||||||||||||||||||
Balance, December 31, 2021
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Current year deferrals to AOCI |
|
|
|
|
||||||||||||||||||||||
Reclassifications from AOCI to Net income |
(
|
|
|
|
||||||||||||||||||||||
Net Change |
(
|
|
|
|
||||||||||||||||||||||
Balance, March 31, 2022
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Current year deferrals to AOCI |
(
|
|
|
(
|
||||||||||||||||||||||
Reclassifications from AOCI to Net income |
(
|
|
|
(
|
||||||||||||||||||||||
Net Change |
(
|
|
|
(
|
||||||||||||||||||||||
Balance, June 30, 2022
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
(In millions) |
Three Months Ended
June 30, |
2023 vs 2022 |
Six Months Ended
June 30, |
2023 vs 2022 | ||||||||||||||||||||||||||||||||||
2023 | 2022 | % change | 2023 | 2022 | % change | |||||||||||||||||||||||||||||||||
Performance Coatings | ||||||||||||||||||||||||||||||||||||||
Refinish | $ | 520.7 | $ | 491.1 | 6.0 | % | $ | 1,018.3 | $ | 952.5 | 6.9 | % | ||||||||||||||||||||||||||
Industrial | 335.3 | 364.7 | (8.1) | % | 684.8 | 717.7 | (4.6) | % | ||||||||||||||||||||||||||||||
Total Net sales Performance Coatings | 856.0 | 855.8 | — | % | 1,703.1 | 1,670.2 | 2.0 | % | ||||||||||||||||||||||||||||||
Mobility Coatings | ||||||||||||||||||||||||||||||||||||||
Light Vehicle | 330.2 | 282.9 | 16.7 | % | 658.7 | 558.5 | 17.9 | % | ||||||||||||||||||||||||||||||
Commercial Vehicle | 107.7 | 96.2 | 12.0 | % | 216.0 | 180.3 | 19.8 | % | ||||||||||||||||||||||||||||||
Total Net sales Mobility Coatings | 437.9 | 379.1 | 15.5 | % | 874.7 | 738.8 | 18.4 | % | ||||||||||||||||||||||||||||||
Total Net sales | $ | 1,293.9 | $ | 1,234.9 | 4.8 | % | $ | 2,577.8 | $ | 2,409.0 | 7.0 | % |
Three Months Ended
June 30, |
2023 vs 2022 |
Six Months Ended
June 30, |
2023 vs 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
2023 | 2022 | $ Change | % Change | 2023 | 2022 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||
Net sales
|
$ | 1,293.9 | $ | 1,234.9 | $ | 59.0 | 4.8 | % | $ | 2,577.8 | $ | 2,409.0 | $ | 168.8 | 7.0 | % | ||||||||||||||||||||||||||||||||||
Price/Mix effect | 6.8 | % | 8.0 | % | ||||||||||||||||||||||||||||||||||||||||||||||
Volume effect
|
(3.7) | % | (0.6) | % | ||||||||||||||||||||||||||||||||||||||||||||||
Impact of one-time events | 1.6 | % | 0.8 | % | ||||||||||||||||||||||||||||||||||||||||||||||
Exchange rate effect
|
0.1 | % | (1.2) | % |
Net sales increased primarily due to the following:
|
||
n
Higher average selling prices and product mix in both segments and all regions, primarily as a result of pricing actions taken to offset cumulative input cost inflation
|
||
n
The absence of a $20.3 million reduction in the prior year period from the Customer Contract Restructuring
|
||
Partially offset by:
|
||
n
Lower sales volumes primarily as a result of temporary operational delays in North America from our multi-year ERP system implementation and a weaker Industrial market environment, partially offset by improved production environments within Mobility Coatings
|
||
n
Impacts of currency translation were immaterial when compared to the prior year period
|
Net sales increased primarily due to the following:
|
||
n
Higher average selling prices and product mix in both segments and all regions, primarily as a result of pricing actions taken to offset input cost inflation
|
||
n
The absence of a $20.3 million reduction in the prior year period from the Customer Contract Restructuring
|
||
Partially offset by:
|
||
n
Unfavorable impacts of currency translation due primarily to the fluctuations of the Chinese Yuan, Turkish Lira, Euro and British Pound, partially offset by the Mexican Peso, compared to the U.S. Dollar
|
||
n
Lower sales volumes primarily as a result of temporary operational delays in North America from our multi-year ERP system implementation and a weaker Industrial market environment, partially offset by improved production environments within Mobility Coatings
|
Three Months Ended
June 30, |
2023 vs 2022 |
Six Months Ended
June 30, |
2023 vs 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
2023 | 2022 | $ Change | % Change | 2023 | 2022 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||
Cost of sales | $ | 904.4 | $ | 886.4 | $ | 18.0 | 2.0% | $ | 1,806.3 | $ | 1,723.8 | $ | 82.5 | 4.8 | % | |||||||||||||||||||||||||||||||||||
% of net sales | 69.9 | % | 71.8 | % | 70.1 | % | 71.6 | % |
Cost of sales increased primarily due to the following:
|
||
n
Higher operating expenses due primarily to increased labor costs
|
||
n
Higher costs of $14.1 million associated with our multi-year ERP system implementation and fees for third-party consultants focused on productivity programs
|
||
n
Impairment charge of $8.3 million due to the decision to demolish assets at a previously closed manufacturing site
|
||
Partially offset by:
|
||
n
Decreased variable input costs across both segments and most regions due to deflation
|
||
n
Decreased costs associated with lower sales volumes
|
||
n
Impacts of currency translation were immaterial when compared to the prior year period
|
||
Cost of sales as a percentage of net sales decreased primarily due to the following:
|
||
n
Higher average selling prices in both segments and all regions
|
||
n
Decreased variable input costs across both segments and most regions due to deflation
|
||
n
The absence of a $20.3 million reduction to net sales in the prior year period from the Customer Contract Restructuring which had no corresponding impact on cost of sales
|
||
Partially offset by:
|
||
n
Higher operating expenses due primarily to increased labor costs
|
||
n
Higher costs of $14.1 million associated with our multi-year ERP system implementation and fees for third-party consultants focused on productivity programs
|
||
n
Impairment charge of $8.3 million due to the decision to demolish assets at a previously closed manufacturing site
|
||
n
Less effective coverage of fixed costs as a result of lower sales volume
|
Cost of sales increased primarily due to the following:
|
||
n
Higher operating expenses due primarily to increased labor costs
|
||
n
Higher costs of $18.4 million associated with our multi-year ERP system implementation and fees for third-party consultants focused on productivity programs
|
||
n
Higher variable input costs in Performance Coatings, partially offset with lower variable input costs in Mobility Coatings
|
||
n
Impairment charge of $8.3 million due to the decision to demolish assets at a previously closed manufacturing site
|
||
n
Increase of $2.8 million in inventory obsolescence charges compared to the prior year period
|
||
Partially offset by:
|
||
n
Favorable currency translation impact of approximately 1%, due primarily to the fluctuations of the Chinese Yuan, Turkish Lira, Euro, British Pound and South African Rand, partially offset by the Mexican Peso, compared to the U.S. Dollar
|
||
Cost of sales as a percentage of net sales decreased primarily due to the following:
|
||
n
Higher average selling prices in both segments and all regions
|
||
n
The absence of a $20.3 million reduction to net sales in the prior year period from the Customer Contract Restructuring which had no corresponding impact on cost of sales
|
||
Partially offset by:
|
||
n
Higher operating expenses due primarily to increased labor costs
|
||
n
Higher costs of $18.4 million associated with our multi-year ERP system implementation and fees for third-party consultants focused on productivity programs
|
||
n
Higher variable input costs in Performance Coatings, partially offset with lower variable input costs in Mobility Coatings
|
||
n
Impairment charge of $8.3 million due to the decision to demolish assets at a previously closed manufacturing site
|
||
n
Increase of $2.8 million in inventory obsolescence charges compared to the prior year period
|
Three Months Ended
June 30, |
2023 vs 2022 |
Six Months Ended
June 30, |
2023 vs 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
2023 | 2022 | $ Change | % Change | 2023 | 2022 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||
SG&A | $ | 210.2 | $ | 191.7 | $ | 18.5 | 9.7 | % | $ | 416.2 | $ | 385.2 | $ | 31.0 | 8.0 | % |
Selling, general and administrative expenses increased primarily due to the following:
|
||
n
Higher operating expenses due primarily to increased labor costs
|
||
n
Increased commissions resulting from increased sales
|
||
n
Impacts of currency translation were immaterial when compared to the prior year period
|
Selling, general and administrative expenses increased primarily due to the following:
|
||
n
Higher operating expenses due primarily to increased labor costs
|
||
n
Increased commissions resulting from increased sales
|
||
n
Increase of $4.7 million in bad debt expense
|
||
Partially offset by:
|
||
n
Favorable currency translation impact of approximately 2%, due primarily to the fluctuations of the Chinese Yuan, Euro and British Pound, partially offset by the Mexican Peso, compared to the U.S. Dollar
|
Three Months Ended
June 30, |
2023 vs 2022 |
Six Months Ended
June 30, |
2023 vs 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
2023 | 2022 | $ Change | % Change | 2023 | 2022 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||
Other operating charges | $ | 2.1 | $ | 4.8 | $ | (2.7) | 56.3 | % | $ | 9.2 | $ | 12.5 | $ | (3.3) | (26.4) | % | ||||||||||||||||||||||||||||||||||
Other operating charges decreased primarily due to the following:
|
||
n
Decrease of $2.3 million in acquisition and divestiture-related costs
|
||
n
Decrease of $0.9 million in site closure costs
|
||
n
Decrease of $0.4 million in termination benefits and other employee-related costs associated with our cost saving initiatives
|
||
Partially offset by:
|
||
n
Increase of $0.9 million from a benefit of $1.0 million in the prior year period to a $0.1 million benefit in the current period as a result of changes in estimates of reserves for accounts receivable related to Russia's conflict with Ukraine
|
Other operating charges decreased primarily due to the following:
|
||
n
Decrease of $4.5 million from an expense of $3.1 million in the prior year period to a benefit of $1.4 million in the current period as a result of changes in estimates of reserves for accounts receivable related to Russia's conflict with Ukraine
|
||
n
Decrease of $3.0 million in termination benefits and other employee-related costs associated with our cost saving initiatives
|
||
n
Decrease of $2.2 million in acquisition and divestitures-related costs in the current year
|
||
n
Decrease of $0.5 million in site closure costs
|
||
Partially offset by:
|
||
n
Impairment charges increased $7.3 million primarily related to the then anticipated exit of a non-core business category in the Mobility Coatings segment recorded during the three months ended March 31, 2023
|
||
Three Months Ended
June 30, |
2023 vs 2022 |
Six Months Ended
June 30, |
2023 vs 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
2023 | 2022 | $ Change | % Change | 2023 | 2022 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||
Research and development expenses
|
$ | 18.6 | $ | 16.7 | $ | 1.9 | 11.4 | % | $ | 37.7 | $ | 33.1 | $ | 4.6 | 13.9 | % |
Research and development expenses increased primarily due to the following:
|
||
n
Increased labor costs
|
||
n
Impacts of currency translation were immaterial when compared to the prior year period
|
Research and development expenses increased primarily due to the following:
|
||
n
Increased labor costs
|
||
n
Impacts of currency translation were immaterial when compared to the prior year period
|
Three Months Ended
June 30, |
2023 vs 2022 |
Six Months Ended
June 30, |
2023 vs 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
2023 | 2022 | $ Change | % Change | 2023 | 2022 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||
Amortization of acquired intangibles
|
$ | 21.0 | $ | 31.7 | $ | (10.7) | (33.8) | % | $ | 45.5 | $ | 64.5 | $ | (19.0) | (29.5) | % |
Amortization of acquired intangibles decreased primarily due to the following:
|
||
n
Reduced amortization from intangibles reaching the end of their useful lives
|
||
n
Impacts of currency translation were immaterial when compared to the prior year period
|
Amortization of acquired intangibles decreased primarily due to the following:
|
||
n
Reduced amortization from certain intangibles reaching the end of their useful lives
|
||
n
Favorable currency translation impact of approximately 1%, due primarily to the fluctuations of the Euro compared to the U.S. Dollar
|
Three Months Ended
June 30, |
2023 vs 2022 |
Six Months Ended
June 30, |
2023 vs 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
2023 | 2022 | $ Change | % Change | 2023 | 2022 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||
Interest expense, net | $ | 54.6 | $ | 33.5 | $ | 21.1 | 63.0 | % | $ | 102.8 | $ | 66.1 | $ | 36.7 | 55.5 | % | ||||||||||||||||||||||||||||||||||
Interest expense, net increased primarily due to the following:
|
||
•
Unfavorable impact of approximately $24.6 million due to the interest rate on the 2029 Dollar Term Loans, which were issued in December 2022 to replace the 2024 Dollar Term Loans
|
||
Partially offset by:
|
||
n
Favorable impact of lower principal balance during the current year period, primarily as a result of $150.0 million of voluntary payments during the current year
|
||
n
Favorable impact of $1.2 million from derivative instruments used to hedge the variable interest rate exposure on certain debt arrangements
|
||
n
Impacts of currency translation were immaterial when compared to the period year period
|
Interest expense, net increased primarily due to the following:
|
||
•
Unfavorable impact of approximately $52.1 million due to the interest rate on the 2029 Dollar Term Loans, which were issued in December 2022 to replace the 2024 Dollar Term Loans
|
||
Partially offset by:
|
||
n
Favorable impact of lower principal balance during the current year period, primarily as a result of $150.0 million of voluntary payments during the current year
|
||
n
Favorable impact of $10.0 million from derivative instruments used to hedge the variable interest rate exposure on certain debt arrangements
|
||
n
Impacts of currency translation were immaterial when compared to the prior year period
|
Three Months Ended
June 30, |
2023 vs 2022 |
Six Months Ended
June 30, |
2023 vs 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
2023 | 2022 | $ Change | % Change | 2023 | 2022 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||
Other expense, net | $ | 8.5 | $ | 7.2 | $ | 1.3 | 18.1 | % | $ | 9.8 | $ | 9.0 | $ | 0.8 | 8.9 | % |
Other expense, net increased primarily due to the following:
|
||
n
Increase in debt extinguishment and refinancing related costs of $1.4 million primarily as a result of $75.0 million of voluntary prepayments during the current period
|
||
n
Unfavorable impact of foreign exchange losses of $4.7 million when compared with the prior year period, including devaluation of net monetary assets denominated in the Argentinian Peso and the Turkish Lira due to hyperinflationary conditions
|
||
Partially offset by:
|
||
n
The absence of a $4.7 million charge recorded in 2022 for the Customer Contract Restructuring
|
Other expense, net increased primarily due to the following:
|
||
n
Increased debt extinguishment and refinancing related costs of $3.2 million, primarily as a result of $150.0 million of voluntary prepayments during the current year and the refinancing of the 2024 Dollar Term Loans
|
||
n
Unfavorable impact of foreign exchange losses of $4.4 million when compared with the prior year period, including devaluation of net monetary assets denominated in the Argentinian Peso and the Turkish Lira due to hyperinflationary conditions
|
||
Partially offset by:
|
||
n
The absence of a $4.7 million charge recorded in 2022 for the Customer Contract Restructuring
|
||
n
Increased miscellaneous income, net of $2.1 million
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Income before income taxes | $ | 74.5 | $ | 62.9 | $ | 150.3 | $ | 114.8 | ||||||||||||||||||
Provision for income taxes | 13.4 | 18.8 | 28.7 | 29.8 | ||||||||||||||||||||||
Statutory U.S. Federal income tax rate
|
21.0 | % | 21.0 | % | 21.0 | % | 21.0 | % | ||||||||||||||||||
Effective tax rate
|
18.0 | % | 29.9 | % | 19.1 | % | 26.0 | % | ||||||||||||||||||
Effective tax rate vs. statutory U.S. Federal income tax rate | (3.0) | % | 8.9 | % | (1.9) | % | 5.0 | % |
(Favorable) Unfavorable Impact | ||||||||||||||||||||||||||
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||||||
Items impacting the effective tax rate vs. statutory U.S. federal income tax rate
|
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Earnings generated in jurisdictions where the statutory rate is different from the U.S. Federal rate
(1)
|
$ | (8.6) | $ | (4.6) | $ | (15.1) | $ | (9.7) | ||||||||||||||||||
Changes in valuation allowance
|
4.9 | 7.9 | 12.7 | 8.9 | ||||||||||||||||||||||
Foreign exchange (gains) losses, net | (0.1) | (5.3) | 0.3 | (3.0) | ||||||||||||||||||||||
Non-deductible expenses and interest
|
1.1 | 1.5 | 2.2 | 2.1 | ||||||||||||||||||||||
Changes in unrecognized tax benefits | (2.7) | 5.0 | (4.9) | 5.1 |
Three Months Ended
June 30, |
2023 vs 2022 |
Six Months Ended
June 30, |
2023 vs 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
2023 | 2022 | $ Change | % Change | 2023 | 2022 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||
Net sales
|
$ | 856.0 | $ | 855.8 | $ | 0.2 | — | % | $ | 1,703.1 | $ | 1,670.2 | $ | 32.9 | 2.0 | % | ||||||||||||||||||||||||||||||||||
Volume effect | (11.1) | % | (7.2) | % | ||||||||||||||||||||||||||||||||||||||||||||||
Price/Mix effect | 8.5 | % | 9.3 | % | ||||||||||||||||||||||||||||||||||||||||||||||
Impact of one-time events | 2.4 | % | 1.2 | % | ||||||||||||||||||||||||||||||||||||||||||||||
Exchange rate effect
|
0.2 | % | (1.3) | % | ||||||||||||||||||||||||||||||||||||||||||||||
Adjusted EBIT | $ | 117.8 | $ | 125.2 | $ | (7.4) | (5.9) | % | $ | 227.1 | $ | 219.8 | $ | 7.3 | 3.3 | % | ||||||||||||||||||||||||||||||||||
Adjusted EBIT Margin
|
13.8 | % | 14.6 | % | 13.3 | % | 13.2 | % |
Net sales remained consistent primarily due to the following:
|
||
n
Higher average selling prices and product mix across both end-markets and all regions, primarily as a result of pricing actions taken to offset cumulative input cost inflation
|
||
n
The absence of a $20.3 million reduction to net sales in the prior year period from the Customer Contract Restructuring, creating a 2.4% benefit in the current year period
|
||
Offset by:
|
||
n
Lower sales volumes across both end-markets and most regions, primarily driven by impacts of temporary operational delays in North America from our multi-year ERP system implementation and a weaker Industrial market environment
|
Adjusted EBIT and Adjusted EBIT margin decreased primarily due to the following:
|
||
n
Lower sales volumes across both end-markets and most regions, primarily driven by impacts of temporary operational delays in North America from our multi-year ERP system implementation and a weaker Industrial market environment
|
||
n
Higher operating expenses due primarily to increased labor costs
|
||
n
Less effective coverage of fixed costs as a result of lower sales volume
|
||
Partially offset by:
|
||
n
Higher average selling prices and product mix across both end-markets and all regions, primarily as a result of pricing actions taken to offset cumulative input cost inflation
|
||
n
Decreased variable input costs due to deflation
|
||
In addition to the factors noted above, the current year period Adjusted EBIT margin was negatively impacted by:
|
||
n
The absence of a $20.3 million reduction to net sales in the prior year period from the Customer Contract Restructuring
|
Net sales increased primarily due to the following:
|
||
n
Higher average selling prices and product mix across both end-markets and all regions, primarily as a result of pricing actions taken to offset input cost inflation
|
||
n
The absence of a $20.3 million reduction in the prior year period from the Customer Contract Restructuring, creating a 1.2% benefit in the current year period
|
||
Partially offset by:
|
||
n
Lower sales volumes across both end-markets and most regions, primarily driven by impacts of temporary operational delays in North America from our multi-year ERP system implementation and a weaker Industrial market environment
|
||
n
Unfavorable impacts of currency translation due primarily to the fluctuations of the Chinese Yuan, Euro, Turkish Lira, British Pound and Swedish Krona, partially offset by the Mexican Peso, compared to the U.S. Dollar
|
Adjusted EBIT and Adjusted EBIT margin increased primarily due to the following:
|
||
n
Higher average selling prices and product mix across both end-markets and all regions, primarily as a result of pricing actions taken to offset input cost inflation
|
||
Partially offset by:
|
||
n
Lower sales volumes across both end-markets and most regions, primarily driven by impacts of temporary operational delays in North America from our multi-year ERP system implementation and a weaker Industrial market environment
|
||
n
Higher operating expenses due primarily to increased labor costs
|
||
n
Higher variable input costs within both end-markets and most regions due to raw material inflation
|
||
n
Less effective coverage of fixed costs as a result of lower sales volume
|
||
In addition to the factors noted above, the current year period Adjusted EBIT margin was negatively impacted by:
|
||
n
The absence of a $20.3 million reduction to net sales in the prior year period from the Customer Contract Restructuring
|
Three Months Ended
June 30, |
2023 vs 2022 |
Six Months Ended
June 30, |
2023 vs 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
2023 | 2022 | $ Change | % Change | 2023 | 2022 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||
Net sales | $ | 437.9 | $ | 379.1 | $ | 58.8 | 15.5 | % | $ | 874.7 | $ | 738.8 | $ | 135.9 | 18.4 | % | ||||||||||||||||||||||||||||||||||
Volume effect | 12.8 | % | 14.7 | % | ||||||||||||||||||||||||||||||||||||||||||||||
Price/Mix effect | 2.7 | % | 4.8 | % | ||||||||||||||||||||||||||||||||||||||||||||||
Exchange rate effect | — | % | (1.1) | % | ||||||||||||||||||||||||||||||||||||||||||||||
Adjusted EBIT | $ | 23.7 | $ | 2.3 | $ | 21.4 | 930.4 | % | $ | 47.2 | $ | 2.8 | $ | 44.4 | 1,585.7 | % | ||||||||||||||||||||||||||||||||||
Adjusted EBIT Margin | 5.4 | % | 0.6 | % | 5.4 | % | 0.4 | % |
Net sales increased primarily due to the following:
|
||
n
Higher sales volumes across both end-markets and all regions, even with some negative impacts of temporary operational delays in North America from our multi-year ERP system implementation
|
||
n
Higher average selling prices and product mix across both end-markets and most regions, primarily as a result of pricing actions taken to offset cumulative input cost inflation
|
Adjusted EBIT and Adjusted EBIT margin increased primarily due to the following:
|
||
n
Decreased variable input costs across both end-markets and most regions due to deflation
|
||
n
Higher sales volumes across both end-markets and all regions, even with some negative impacts of temporary operational delays in North America from our multi-year ERP system implementation
|
||
n
Higher average selling prices and product mix across both end-markets and most regions, primarily as a result of pricing actions taken to offset cumulative input cost inflation
|
||
Partially offset by:
|
||
n
Higher operating expenses due primarily to increased labor costs
|
Net sales increased primarily due to the following:
|
||
n
Higher sales volumes across both end-markets and all regions, even with some negative impacts of temporary operational delays in North America from our multi-year ERP system implementation
|
||
n
Higher average selling prices and product mix across both end-markets and all regions, primarily as a result of pricing actions taken to offset cumulative input cost inflation
|
||
Partially offset by:
|
||
n
Unfavorable impacts of currency translation due primarily to the fluctuations of the Chinese Yuan, Turkish Lira, South African Rand and Euro, partially offset by the Mexican Peso, compared to the U.S. Dollar.
|
Adjusted EBIT and Adjusted EBIT margin increased primarily due to the following:
|
||
n
Higher average selling prices and product mix across both end-markets and all regions, primarily as a result of pricing actions taken to offset input cost inflation
|
||
n
Higher sales volumes across both end-markets and all regions, even with some negative impacts of temporary operational delays in North America from our multi-year ERP system implementation
|
||
n
Decreased variable input costs across both end-markets and most regions due to deflation
|
||
Partially offset by:
|
||
n
Higher operating expenses due primarily to increased labor costs
|
Six Months Ended
June 30, |
||||||||||||||
(In millions) | 2023 | 2022 | ||||||||||||
Net cash provided by (used for): | ||||||||||||||
Operating activities: | ||||||||||||||
Net income | $ | 121.6 | $ | 85.0 | ||||||||||
Depreciation and amortization | 135.7 | 155.0 | ||||||||||||
Amortization of deferred financing costs and original issue discount | 4.3 | 4.8 | ||||||||||||
Debt extinguishment and refinancing related costs | 3.0 | (0.2) | ||||||||||||
Deferred income taxes | 0.5 | 2.0 | ||||||||||||
Realized and unrealized foreign exchange losses, net | 18.8 | 4.9 | ||||||||||||
Stock-based compensation | 13.6 | 9.0 | ||||||||||||
Divestiture and impairment charges | 15.4 | 0.7 | ||||||||||||
Interest income on swaps designated as net investment hedges | (6.1) | (10.0) | ||||||||||||
Commercial agreement restructuring charge | — | 25.0 | ||||||||||||
Other non-cash, net | 1.0 | (7.1) | ||||||||||||
Net income adjusted for non-cash items | 307.8 | 269.1 | ||||||||||||
Changes in operating assets and liabilities | (228.6) | (300.8) | ||||||||||||
Operating activities | 79.2 | (31.7) | ||||||||||||
Investing activities | (37.0) | (38.1) | ||||||||||||
Financing activities | (179.2) | (260.2) | ||||||||||||
Effect of exchange rate changes on cash | 2.1 | (11.0) | ||||||||||||
Net decrease in cash | $ | (134.9) | $ | (341.0) |
(In millions) | June 30, 2023 | December 31, 2022 | ||||||||||||
2029 Dollar Term Loans | $ | 1,845.0 | $ | 2,000.0 | ||||||||||
2025 Euro Senior Notes | 491.1 | 479.1 | ||||||||||||
2027 Dollar Senior Notes | 500.0 | 500.0 | ||||||||||||
2029 Dollar Senior Notes | 700.0 | 700.0 | ||||||||||||
Short-term and other borrowings | 75.3 | 74.5 | ||||||||||||
Unamortized original issue discount | (19.5) | (22.4) | ||||||||||||
Unamortized deferred financing costs | (24.0) | (26.9) | ||||||||||||
Total borrowings, net | 3,567.9 | 3,704.3 | ||||||||||||
Less: | ||||||||||||||
Short-term borrowings | 19.0 | 16.0 | ||||||||||||
Current portion of long-term borrowings | 20.0 | 15.0 | ||||||||||||
Long-term debt | $ | 3,528.9 | $ | 3,673.3 |
EXHIBIT NO.
|
DESCRIPTION OF EXHIBITS
|
||||
10.1* | |||||
10.2 | |||||
31.1 | |||||
31.2 | |||||
32.1† | |||||
32.2† | |||||
101 | INS - Inline XBRL Instance Document. The document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document | ||||
101 | SCH - Inline XBRL Taxonomy Extension Schema Document | ||||
101 | CAL - Inline XBRL Taxonomy Extension Calculation Linkbase Document | ||||
101 | DEF - Inline XBRL Taxonomy Extension Definition Linkbase Document | ||||
101 | LAB - Inline XBRL Taxonomy Extension Label Linkbase Document | ||||
101 | PRE - Inline XBRL Taxonomy Extension Presentation Linkbase Document | ||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | ||||
* |
Previously filed.
|
||||
^ | Denotes management contract or compensatory plan or arrangement. | ||||
† | This certificate is being furnished solely to accompany the report pursuant to 18 U.S.C. Section 1350 and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. |
AXALTA COATING SYSTEMS LTD. | |||||||||||
Date: | August 1, 2023 | By: /s/ Chris Villavarayan | |||||||||
Chris Villavarayan | |||||||||||
Chief Executive Officer and President | |||||||||||
(Principal Executive Officer) | |||||||||||
Date: | August 1, 2023 | By: /s/ Sean M. Lannon | |||||||||
Sean M. Lannon | |||||||||||
Senior Vice President and Chief Financial Officer | |||||||||||
(Principal Financial Officer) | |||||||||||
Date: | August 1, 2023 | By: /s/ Anthony Massey | |||||||||
Anthony Massey | |||||||||||
Vice President and Global Controller | |||||||||||
(Principal Accounting Officer) |
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Customer name | Ticker |
---|---|
Snap-on Incorporated | SNA |
No Suppliers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|